•     Testimonials      •     Verdicts      •     Bios      •

Contact Us

Case Review Form
* Denotes required field.

Injury Topic
(Name of Drug or Device)

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Please describe your case:

Date of Incident
(mm-dd-yyyy):

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

New Call To Ban Celebrex and Bextra

Feb 1, 2005 | AP A consumer watchdog group is renewing its call that the arthritis drug Celebrex and Bextra be pulled off the market.

Public Citizen is claiming drug-maker Pfizer acknowledged that patients given Celebrex in a 1999 study had about four times the risk of heart attack of those taking a placebo.

It wants Celebrex and a similar drug, Bextra, to be withdrawn.

Pfizer has insisted no definitive conclusions could be drawn from the study.

Similar findings surrounding Vioxx prompted manufacturer Merck, to stop selling the pain remedy in September 2004. [ Vioxx pulled ]

All three medications are in a class known as "COX-2 inhibitors," which is under study by the Food and Drug Administration.